Issac Balachandran talks about his success as a film editor
March 22, 2022
Shenzhen Port’s annual container throughput up 8.4 pct in 2021
January 6, 2022
Aurobindo Pharma Ltd on Tuesday said its wholly-owned arm Eugia Pharma Specialities has received a final approval from the US ...
Aurobindo Pharma, India's second-largest drug maker by revenue, has set its sights on becoming a $5 billion revenue company within ...
Aurobindo Pharma Ltd on Wednesday said its wholly-owned subsidiary APL Healthcare has received a final approval from the US health ...
CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma said it has entered into an exclusive license agreement with the ...
US Food and Drug Administration officials found multiple faults at a plant run by one of India’s biggest drugmakers as ...
Aurobindo Pharma on Friday said its wholly-owned arm, Eugia Pharma Specialities Ltd has entered into a voluntary sub-licensing agreement with ...
ViiV Healthcare, jointly owned by GSK, Pfizer and Shionogi together with the UN's Medicine Patent Pool (MPP) on Thursday issued ...
Aurobindo Pharma on Thursday said three manufacturing units in Jadcherla, Telangana, inspected by USFDA in January have been classified as ...
Aurobindo Pharma on Wednesday said its unit has entered into a licensing pact with Evive Biotech to commercialise Ryzneuta in ...
Aurobindo Pharma's aims to complete its Rs 2,000 crore Penicillin G (Pen G) plant in Andhra Pradesh by March 2024 ...
Copyright © 2021 Asia Post.
Asia Post is not responsible for the content of external sites.